欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/V/0247/001
药品名称ATIPAZOLE / ANTIDORM
活性成分
    • atipamezole chlorohydrate 4.27 mg
剂型Solution for injection
上市许可持有人VETPHARMA ANIMAL HEALTH LES CORTS, 23 08028 BARCELONE ESPAGNE
参考成员国 - 产品名称France (FR)
ANTIDORM (13443)
互认成员国 - 产品名称
    • Germany (DE)
      Atipazole
    • Belgium (BE)
      Atipazole 5 mg/ml
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
      Atopazole 5mg/ml solution for injection for dogs and cats
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
      Atipazole 5 mg/ml solution for injection for dogs and cats
    • Latvia (LV)
      Atipazole
    • Lithuania (LT)
      ATIPAZOLE 5mg/ml injekcinis tirpalas šunims ir katėms
    • Hungary (HU)
    • Bulgaria (BG)
    • Slovenia (SI)
    • Cyprus (CY)
许可日期2013/06/26
最近更新日期2023/11/04
药物ATC编码
    • QV03AB90 atipamezole
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase